Oct 29 (Reuters) - Drugstore chain CVS Health Corp (N:CVS) CVS.N
said it had dropped Philidor Rx, a specialty pharmacy associated
with Valeant Pharmaceuticals (N:VRX) Inc VRX.TO VRX.N , from its
Caremark program.
Valeant's shares tumbled last week after influential
short-seller Citron Research said the company was using
specialty pharmacies to inflate revenue.
CVS took the step following an audit of Philidor, citing
"noncompliance" with its provider agreement.